Title of article :
In vitro and in vivo toxicity and histopathological evaluation of Gd(III)anionic Linear globular dendrimer secondgeneration G2-C595 nanoprobe
Author/Authors :
Mirzaei ، Mehdi Cancer Research Center - Shahid Beheshti University of Medical Sciences , Esmaeil Akbari ، Mohammad Cancer Research Center - Shahid Beheshti University of Medical Sciences , Mohagheghi ، Mohammad Ali Cancer Institute Research Center - Tehran University of Medical Sciences , Tavangar ، Mohammad Department of Pathology - Shariati Hospital - Tehran University of Medical Sciences , Mehravi ، Bita Department of Medical Nanotechnology - Faculty of Advanced Technologies in Medicine - Iran University of Medical Sciences , Shafiee Ardestani ، Mehdi Department of Radiopharmacy - School of Pharmacy - Tehran University of Medical Sciences
Abstract :
Objective(s): Toxico-histopathological studies are used to assess the toxic impacts of nanoparticles in organism exposure. The present study aimed to evaluate the prospective nano-cytotoxicity impacts of Gd(III)-anionic linear globular dendrimer second-generation G2-C595 (Gd[III] dendrimer G2-C595) contrast nanoprobe in terms of the exposure of many nude mice organs and organisms. In addition, we assessed the potential of the Gd(III)-dendrimer G2-C595 nanoprobe as a novel magnetic resonance imaging (MRI) nano-contrast agent for the human breast cancer cell line (MCF-7) and human embryonic kidney cell line (HEK-293). Materials and Methods: Gadolinium (Gd[III]) was loaded with dendrimer G2 and conjugated with the C595 monoclonal antibody to generate the Gd(III)-dendrimer G2-C595 to determine the impact on MUC1 beneficial cancer tumors. The cytotoxic effects of the Gd(III)-dendrimer G2-C595 nanoprobe on the HEK- 293 cells were also investigated in-vitro and in-vivo. In addition, the Gd(III)-dendrimer G2-C595 nanoprobe was used on nude mice bearing the MCF-7 tumors to explore its specific activity against the in-vivo model of cancer. Results: The Gd(III)-dendrimer G2-C595 contrast nanoprobes affected the cytotoxicity of MCF-7, and no in-vivo toxicity was induced in the HEK-293 cells, kidneys, heart, lungs, brain, liver tissues, and other organs. Conclusion: According to the results, the Gd(III)-dendrimer G2 and Gd(III)-dendrimer G2-C595 induced no toxicity in the HEK-293 cells and heart, liver, and brain tissues of mice. In addition, the Gd(III)-dendrimer G2-C595 showed specific anti-action against the in-vivo tumor model. Therefore, the Gd(III)-dendrimer G2-C595 nanoprobe is highly recommended as a novel and effective MR contrast agent and antitumor carrier agent. Furthermore, the Gd(III)-dendrimer G2-C595 nano-sized probes demonstrated excellent biocompatibility and safety with no impact on normal organ functioning.
Keywords :
Gd(III) , Dendrimer G2 , C595 Nanoprobe , Human Embryonic Kidney Cells (HEK , 293) , Human Breast Cancer Cell Line (MCF , 7) , Nanoparticle Toxicity
Journal title :
Nanomedicine Journal
Journal title :
Nanomedicine Journal